SCHEMBL5229696

SCHEMBL5229696

COc1ccc(/C=N/c2c(C)nn(-c3ccccc3)c2N)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 11/20 0.60
RAB9A P51151 10/20 0.60
NPC1 O15118 9/20 0.60
HPGD P15428 7/20 0.60
POLB P06746 2/20 0.60
MAPT P10636 12/20 0.53
TDP1 Q9NUW8 6/20 0.53
ALDH1A1 P00352 4/20 0.53
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
MAPK1 P28482 4/20 0.49
L3MBTL1 Q9Y468 4/20 0.48
ALOX12 P18054 2/20 0.48
HTT P42858 1/20 0.48
LMNA P02545 4/20 0.47
KDM4E B2RXH2 2/20 0.47
NPSR1 Q6W5P4 2/20 0.46
GAA P10253 3/20 0.45
APAF1 O14727 1/20 0.42
USP2 O75604 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5229703 1.00 SMN1; SMN2 (0.60) SMN1; SMN2RAB9ANPC1HPGDPOLB
SCHEMBL5655367 0.75 SMN1; SMN2 (0.68) SMN1; SMN2RAB9ANPC1HPGDPOLB
SCHEMBL13860516 0.70 SMN1; SMN2 (0.60) SMN1; SMN2RAB9ANPC1HPGDPOLB
SCHEMBL1804029 0.70 LMNA (0.61) SMN1; SMN2RAB9ANPC1HPGDPOLB
SCHEMBL11700016 0.70 LMNA (0.61) SMN1; SMN2RAB9ANPC1HPGDPOLB
SCHEMBL8999235 0.70 SMN1; SMN2 (1.00) SMN1; SMN2RAB9ANPC1HPGDPOLB
SCHEMBL8999229 0.70 SMN1; SMN2 (1.00) SMN1; SMN2RAB9ANPC1HPGDPOLB
SCHEMBL9567876 0.68 RAB9A (0.58) SMN1; SMN2RAB9ANPC1HPGDPOLB
SCHEMBL9567877 0.68 RAB9A (0.58) SMN1; SMN2RAB9ANPC1HPGDPOLB
SCHEMBL8999386 0.68 RAB9A (0.72) SMN1; SMN2RAB9ANPC1HPGDPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1817379-A2 PYRAZOLE AZOMETHINES AND COLORANTS CONTAINING THESE COMPOUNDS The Procter and Gamble Company (US) 2007-08-15 EP claimed
US-20070033742-A1 Pyrazole azomethines and colorants containing these compounds PROCTER & GAMBLE COMPANY, THE 2007-02-15 US claimed
WO-2006060564-A2 PYRAZOLE AZOMETHINES AND COLORANTS CONTAINING THESE COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2006-06-08 WO claimed
EP-1817379-A2 PYRAZOLE AZOMETHINES AND COLORANTS CONTAINING THESE COMPOUNDS The Procter and Gamble Company (US) 2007-08-15 EP disclosed
US-20070033742-A1 Pyrazole azomethines and colorants containing these compounds PROCTER & GAMBLE COMPANY, THE 2007-02-15 US disclosed
US-20070033742-A1 Pyrazole azomethines and colorants containing these compounds PROCTER & GAMBLE COMPANY, THE 2007-02-15 US disclosed
US-20070033742-A1 Pyrazole azomethines and colorants containing these compounds PROCTER & GAMBLE COMPANY, THE 2007-02-15 US disclosed
WO-2006060564-A2 PYRAZOLE AZOMETHINES AND COLORANTS CONTAINING THESE COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2006-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070033742-A1 Pyrazole azomethines and colorants containing these compounds KRT18, NOX5, TUBB3 SMN1; SMN2 4744/4885RAB9A 3691/4885NPC1 4751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.